Drugs / GL-0719
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05318534 | Apr 2022 → Jun 2026 overdue | — | Gliknik Inc. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GL-0719 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05318534 ↗ |
| Route | Intravenous | “Administration route: intravenous infusion and subcutaneous injection” NCT05318534 ↗ |
| Route | Subcutaneous | “Administration route: intravenous infusion and subcutaneous injection” NCT05318534 ↗ |